Brachytherapy
Volume 6, Issue 1 , Pages 34-37, January 2007

American Brachytherapy Society recommends no change for prostate permanent implant dose prescriptions using iodine-125 or palladium-103

  • Mark J. Rivard

      Affiliations

    • Departments of Radiation Oncology and Medical Physics, Tufts-New England Medical Center, Boston, MA
    • Corresponding Author InformationCorresponding author. Tufts-New England Medical Center, Radiation Oncology, Medical Physics, #246, 750 Washington Street, Boston, MA 02111, USA. Tel.: +1-617-636-1680; fax: +1-617-636-7621.
    • ,
  • Wayne M. Butler

      Affiliations

    • Schiffler Cancer Center and Wheeling Jesuit University, Wheeling, WV
    • ,
  • Phillip M. Devlin

      Affiliations

    • Department of Radiation Oncology, Brigham and Women's Hospital, Boston, MA
    • ,
  • John K. Hayes Jr.

      Affiliations

    • GammaWest Brachytherapy, Salt Lake City, UT
    • ,
  • Robert A. Hearn

      Affiliations

    • Theragenics Corporation, Buford, GA
    • ,
  • Eugene P. Lief

      Affiliations

    • Department of Radiation Oncology, Mount Sinai Medical Center, New York, NY
    • ,
  • Ali S. Meigooni

      Affiliations

    • Department of Radiation Medicine, University of Kentucky, Lexington, KY
    • ,
  • Gregory S. Merrick

      Affiliations

    • Schiffler Cancer Center and Wheeling Jesuit University, Wheeling, WV
    • ,
  • Jeffrey F. Williamson

      Affiliations

    • Department of Radiation Oncology, Medical College of Virginia, Richmond, VA

Received 31 August 2006; received in revised form 28 October 2006; accepted 7 November 2006.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 The following authors have received financial support from Theragenics Corporation: PMD, RAH, JFW.

PII: S1538-4721(06)00276-5

doi:10.1016/j.brachy.2006.11.001

Brachytherapy
Volume 6, Issue 1 , Pages 34-37, January 2007

Article Tools